Literature DB >> 2655997

Defective epithelial ion transport in cystic fibrosis.

P M Quinton1.   

Abstract

In America, cystic fibrosis (CF) is the most common fatal inherited disease. In the past few years new concepts have evolved regarding the etiology of CF, changing from an almost universal acceptance of the abnormality as a disease of abnormal mucus production to that of a disease of abnormal fluid and electrolyte transport. Although mucus production is increased, this probably occurs as a secondary defense or protection against more primary disturbances in electrolyte transport brought on by a defect in Cl- permeability that affects both fluid absorption and fluid secretion. Here I review the progress that has been made and some of the puzzles uncovered in recent investigations of electrolyte transport in secretory and absorptive processes in cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2655997

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  9 in total

Review 1.  Pharmacokinetics of drugs in cystic fibrosis.

Authors:  M Spino
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

2.  Cystic fibrosis presenting as hyponatraemic heat exhaustion.

Authors:  H R Smith; G S Dhatt; W M Melia; J G Dickinson
Journal:  BMJ       Date:  1995-03-04

3.  Structure of two sulphated oligosaccharides from respiratory mucins of a patient suffering from cystic fibrosis. A fast-atom-bombardment m.s. and 1H-n.m.r. spectroscopic study.

Authors:  G Lamblin; H Rahmoune; J M Wieruszeski; M Lhermitte; G Strecker; P Roussel
Journal:  Biochem J       Date:  1991-04-01       Impact factor: 3.857

4.  Cystic fibrosis with three mutations in the cystic fibrosis transmembrane conductance regulator gene.

Authors:  T Dörk; U Wulbrand; T Richter; T Neumann; H Wolfes; B Wulf; G Maass; B Tümmler
Journal:  Hum Genet       Date:  1991-08       Impact factor: 4.132

5.  Mycoplasma pulmonis inhibits electrogenic ion transport across murine tracheal epithelial cell monolayers.

Authors:  L C Lambert; H Q Trummell; A Singh; G H Cassell; R J Bridges
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

6.  NVP-QBE170: an inhaled blocker of the epithelial sodium channel with a reduced potential to induce hyperkalaemia.

Authors:  K J Coote; D Paisley; S Czarnecki; M Tweed; H Watson; A Young; R Sugar; M Vyas; N J Smith; U Baettig; P J Groot-Kormelink; M Gosling; R Lock; B Ethell; G Williams; A Schumacher; J Harris; W M Abraham; J Sabater; C T Poll; T Faller; S P Collingwood; H Danahay
Journal:  Br J Pharmacol       Date:  2015-04-23       Impact factor: 8.739

7.  Measurement of intracellular mediators in enterocytes isolated from jejunal biopsy specimens of control and cystic fibrosis patients.

Authors:  B W Hitchin; P R Dobson; B L Brown; J Hardcastle; P T Hardcastle; C J Taylor
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

8.  The chloride channel blocker anthracene 9-carboxylate inhibits fatty acid incorporation into phospholipid in cultured human airway epithelial cells.

Authors:  J X Kang; S F Man; N E Brown; P A Labrecque; M T Clandinin
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

9.  Evaluation of continuous constant current and continuous pulsed current in sweat induction for cystic fibrosis diagnosis.

Authors:  Carla Cristina Souza Gomez; Fernando Augusto Lima Marson; Maria Fátima Servidoni; Antônio Fernando Ribeiro; Maria Ângela Gonçalves Oliveira Ribeiro; Veruska Acioli Lopes Gama; Eduardo Tavares Costa; José Dirceu Ribeiro; Francisco Ubaldo Vieira Junior
Journal:  BMC Pulm Med       Date:  2018-09-14       Impact factor: 3.317

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.